相关实验视频

Updated: Oct 15, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

在多发性骨髓瘤中进行益处风险评估的PROACT-URL和MCDA:一个案例研究

Sidney Marcel Domingues¹, Erica Aranha Suzumura², Alessandro Gonçalves Campolina^1,2

¹Departamento de Medicina Preventiva, Faculdade de Medicina - FMUSP, Universidade de São Paulo, São Paulo, Brazil.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

|September 4, 2025

概括

问题,目标,替代方案,后果,权衡,不确定性,风险和相关决策 (PrOACT-URL) 和多标准决策分析 (MCDA) 框架为医疗技术评估提供了一种新方法. 在多发性骨髓瘤中,循环胺,沙利多米德和德克萨米松 (CTD) 治疗方案显示出最佳的益处风险平衡.

科学领域:

卫生政策和管理
决策分析
药物经济学

背景情况:

将新技术纳入巴西统一卫生系统 (SUS) 需要强有力的决策框架.
评估治疗的益处与风险的平衡对于公共卫生保健的资源分配至关重要.

研究的目的:

评估PrOACT-URL和MCDA框架作为技术评估的创新工具.
使用这些框架进行多发性骨髓瘤化疗选择的益处风险评估.

主要方法:

在多发性骨髓瘤的化疗方案中采用了PROACT-URL和MCDA的案例研究方法.
使用PrOACT-URL进行的定性分析与量化MCDA进行了利益风险评估.
进行了敏感性分析,以评估利益相关者的偏好的影响.

主要成果:

单独使用PrOACT-URL框架是不够的,因此需要整合MCDA.
总体生存是关键的益处,而血栓形成和神经病变是显著的风险.
在各利益相关者群体中,循环胺,thalidomide 和 dexamethasone (CTD) 治疗表现出最有利的益处风险概况.

结论:

联合PrOACT-URL和MCDA的方法提高了医疗保健技术决策的透明度和利益相关者的参与度.
基于其优越的益处风险平衡,推使用CTD疗法治疗多发性骨髓瘤.
这项研究强调了公共卫生系统中结构化的决策方法的价值.

关键词:

生物医学技术的评估进行决策多发性骨髓瘤风险测量作为主题的单个案例研究

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...